After Donald Trump signed an executive order slashing drug prices last week, experts have highlighted how PBMs could be hit the hardest despite pharmaceutical companies facing the potential of compressed margins amid poor pricing power.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
